Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating ?v?5 vitronectin receptor cell surface expression
Open Access
- 22 October 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 102 (6) , 562-571
- https://doi.org/10.1002/ijc.10744
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The microenvironment of the tumour–host interfaceNature, 2001
- Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In VivoMolecular Biology of the Cell, 2001
- Cyclo19,31[D-Cys19]-uPA19-31 Is a Potent Competitive Antagonist of the Interaction of Urokinase-Type Plasminogen Activator with Its Receptor (CD87)Biological Chemistry, 2001
- Urokinase receptor-dependent and -independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherenceThe EMBO Journal, 1999
- Cancer invasion and tissue remodeling‐cooperation of protease systems and cell typesAPMIS, 1999
- General mechanisms of metastasisCancer, 1997
- Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migrationCurrent Opinion in Cell Biology, 1997
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- Phosphorylation of Human Pro-Urokinase on Ser138/303 Impairs Its Receptor-dependent Ability to Promote Myelomonocytic Adherence and MotilityThe Journal of cell biology, 1997
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996